0001576427-23-000083.txt : 20230607
0001576427-23-000083.hdr.sgml : 20230607
20230607160831
ACCESSION NUMBER: 0001576427-23-000083
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230605
FILED AS OF DATE: 20230607
DATE AS OF CHANGE: 20230607
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Balla Nathalie
CENTRAL INDEX KEY: 0001711277
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36153
FILM NUMBER: 23999045
MAIL ADDRESS:
STREET 1: C/O CRITEO, 32 RUE BLANCHE
CITY: PARIS
STATE: I0
ZIP: 75009
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Criteo S.A.
CENTRAL INDEX KEY: 0001576427
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-ADVERTISING AGENCIES [7311]
IRS NUMBER: 000000000
STATE OF INCORPORATION: I0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 32 RUE BLANCHE
CITY: PARIS
STATE: I0
ZIP: 75009
BUSINESS PHONE: 33140402290
MAIL ADDRESS:
STREET 1: 32 RUE BLANCHE
CITY: PARIS
STATE: I0
ZIP: 75009
4
1
wf-form4_168616850077547.xml
FORM 4
X0407
4
2023-06-05
0
0001576427
Criteo S.A.
CRTO
0001711277
Balla Nathalie
C/O CRITEO LEGAL DEPT.
387 PARK AVENUE SOUTH, 12TH FLOOR
NEW YORK
NY
10016
1
0
0
0
0
Ordinary Shares
2023-06-05
4
M
0
6095
18.71
A
23895
D
Ordinary Shares
2023-06-05
4
S
0
6095
33.50
D
17800
D
Non-employee Warrant (right to buy)
18.71
2023-06-05
4
M
0
6095
0
D
2029-10-24
Ordinary Shares
6095.0
3302
D
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
The exercise price of the non-employee warrant is 17.44 euros. The U.S. dollar equivalent of the exercise price is $18.71 using the exchange rate as of June 5, 2023 (1.00 = $ 1.073).
For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.
The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $33.44 to $33.685 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Warrant granted on October 24, 2019. One-fourth of the grant vested on the first anniversary of the grant date and an additional 1/16th of the grant vested quarterly thereafter. Warrant is set to expire on October 24, 2029.
/s/ Ryan Damon, as attorney-in-fact for Nathalie Balla
2023-06-07